Vitamin A: biomarkers of nutrition for development
- PMID: 21715511
- PMCID: PMC3142734
- DOI: 10.3945/ajcn.110.005777
Vitamin A: biomarkers of nutrition for development
Abstract
Vitamin A is essential for multiple functions in mammals. Without vitamin A, mammals cannot grow, reproduce, or fight off disease. Because of its numerous functions in humans, biomarkers of vitamin A status are quite diverse. Assessment of liver reserves of vitamin A is considered the gold standard because the liver is the major storage organ. However, this measure is not feasible in human studies. Alternative biomarkers of status can be classified as biological, functional, histologic, and biochemical. Historically, signs of xerophthalmia were used to determine vitamin A deficiency. Before overt clinical damage to the eye, individuals who suffer from vitamin A deficiency are plagued by night blindness and longer vision-restoration times. These types of assessments require large population-based evaluations. Therefore, surrogate biochemical measures of vitamin A status, as defined by liver reserves, have been developed. Serum retinol concentrations are a common method used to evaluate vitamin A deficiency. Serum retinol concentrations are homeostatically controlled until liver reserves are dangerously low. Therefore, other biochemical methods that respond to liver reserves in the marginal category were developed. These included dose-response tests and isotope dilution assays. Dose-response tests work on the principle that apo-retinol-binding protein builds up in the liver as liver reserves become depleted. A challenge dose of vitamin A binds to this protein, and serum concentrations increase within a few hours if liver vitamin A concentrations are low. Isotope dilution assays use stable isotopes as tracers of total body reserves of vitamin A and evaluate a wide range of liver reserves. Resources available and study objectives often dictate the choice of a biomarker.
Figures
References
-
- Ross SA, McCaffery PJ, Drager UC, De Luca LM. Retinoids in embryonal development. Physiol Rev 2000;80:1021–54 - PubMed
-
- World Health Organization Global Database on Vitamin A Deficiency 2009. Global prevalence of vitamin A deficiency in populations at risk 1995-2005. Available from: http://www.who.int/vmnis/vitamina/en/ (cited April 2010)
-
- Tanumihardjo SA. Assessing vitamin A status: past, present and future. J Nutr 2004;134:290S–3S - PubMed
-
- World Health Organization Indicators for assessing vitamin A deficiency and their application in monitoring and evaluating intervention programmes. WHO/NUT/96.10. Geneva, Switzerland: World Health Organization, 1996
-
- Haskell MJ, Pandey P, Graham JM, Peerson JM, Shrestha RK, Brown KH. Recovery from impaired dark adaptation in nightblind pregnant Nepali women who receive small daily doses of vitamin A as amaranth leaves, carrots, goat liver, vitamin A-fortified rice, or retinyl palmitate. Am J Clin Nutr 2005;81:461–71 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
